Cleveland BioLabs Company Profile (NASDAQ:CBLI)

About Cleveland BioLabs

Cleveland BioLabs logoCleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company's programs are focused developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is entolimod, an immuno-stimulatory agent, which the Company is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. It also has an additional clinical-stage program and multiple projects in different stages of preclinical drug development. Its products include Entolimod, CBLB612, CBL0137 and Mobilan. Entolimod is a toll-like receptor 5 (TLR5). CBLB612 is a compound-based upon a natural activator of another tissue-specific component of the immune system. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBLI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.61
  • 50 Day Moving Average: $1.9809
  • 200 Day Moving Average: $2.3761
  • 52-Week Range: $1.55 - $4.89
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $18.67M
  • Outstanding Shares: 10,987,000
  • Beta: 0.9
Profitability:
  • Net Margins: -27.51%
  • Return on Equity: -7.42%
  • Return on Assets: -5.13%
Debt:
  • Current Ratio: 3.66%
  • Quick Ratio: 3.66%
Additional Links:
Companies Related to Cleveland BioLabs:

Analyst Ratings

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cleveland BioLabs (NASDAQ:CBLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/15/2016Q2($0.17)ViewN/AView Earnings Details
5/16/2016Q116($0.06)ViewN/AView Earnings Details
2/22/2016Q4($0.03)ViewN/AView Earnings Details
11/5/2015Q315($0.31)$415.00 millionViewN/AView Earnings Details
8/12/2015Q215($1.12)$562.10 million$329.90 millionViewListenView Earnings Details
5/6/2015Q115($1.14)$1.33 millionViewN/AView Earnings Details
2/24/2015Q114($1.02)$3.87 million$1.39 millionViewN/AView Earnings Details
8/7/2014Q2($0.09)ViewN/AView Earnings Details
5/8/2014($0.05)($0.03)ViewN/AView Earnings Details
3/11/2014Q413($0.12)($0.01)$1.74 million$3.87 millionViewN/AView Earnings Details
11/6/2013Q313($0.14)($0.09)$1.61 million$1.60 millionViewN/AView Earnings Details
8/13/2013Q2 2013($0.16)($0.07)$1.48 million$1.60 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.17)($0.22)$1.73 million$1.37 millionViewN/AView Earnings Details
11/8/2012Q312($0.02)($0.30)$23.87 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cleveland BioLabs (NASDAQ:CBLI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cleveland BioLabs (NASDAQ:CBLI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cleveland BioLabs (NASDAQ:CBLI)
Insider Ownership Percentage: 3.21%
Institutional Ownership Percentage: 3.72%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/25/2015Randy S SaluckDirectorBuy1,891$3.42$6,467.22View SEC Filing  
5/21/2013Paul E DicorletoDirectorBuy6,210$1.61$9,998.10View SEC Filing  
5/17/2013Randy S SaluckDirectorBuy3,500$1.60$5,600.00View SEC Filing  
3/15/2013James AntalDirectorBuy3,700$1.56$5,772.00View SEC Filing  
9/21/2012James AntalDirectorBuy2,316$2.60$6,021.60View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cleveland BioLabs (NASDAQ:CBLI)
DateHeadline
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : September 12, 2016 (NASDAQ:CBLI)
www.capitalcube.com - September 12 at 3:57 PM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : August 30, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 30 at 11:57 AM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : August 19, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 19 at 4:45 PM
capitalcube.com logoCleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 18 at 12:31 PM
News IconCleveland Biolabs Inc. Reports Second Quarter 2016 Financial Results And Development Progress (NASDAQ:CBLI)
www.biospace.com - August 17 at 12:19 PM
publicnow.com logoCleveland BioLabs Reports Second Quarter 2016 Financial Results and Development Progress (NASDAQ:CBLI)
www.publicnow.com - August 15 at 11:20 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CBLI)
biz.yahoo.com - July 22 at 4:22 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta (NASDAQ:CBLI)
biz.yahoo.com - July 21 at 6:05 AM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : July 19, 2016 (NASDAQ:CBLI)
www.capitalcube.com - July 19 at 12:08 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand (NASDAQ:CBLI)
biz.yahoo.com - July 12 at 4:25 PM
publicnow.com logoCleveland BioLabs Announces Board Resignations (NASDAQ:CBLI)
www.publicnow.com - July 12 at 9:13 AM
fxpips.com logoServices Sector Daily Watch: Winners & Losers (NASDAQ:CBLI)
www.fxpips.com - June 22 at 8:51 AM
capitalcube.com logoCleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CBLI)
www.capitalcube.com - May 17 at 12:26 PM
fxpips.com logoFriday Morning’s Top Movers – UNIS, HTGM, ORMP, NVDA, CETX, CBLI, RUN (NASDAQ:CBLI)
www.fxpips.com - May 16 at 2:01 PM
publicnow.com logoCleveland BioLabs Reports First Quarter 2016 Financial Results and Development Progress (NASDAQ:CBLI)
www.publicnow.com - May 16 at 8:02 AM
bizjournals.com logo22nd Century to begin cannabis research at new medical campus labs (NASDAQ:CBLI)
www.bizjournals.com - May 12 at 2:40 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit (NASDAQ:CBLI)
biz.yahoo.com - May 6 at 5:55 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CBLI)
biz.yahoo.com - April 15 at 3:05 PM
publicnow.com logoCleveland BioLabs Announces Webcast of Annual Meeting (NASDAQ:CBLI)
www.publicnow.com - April 4 at 7:37 AM
rttnews.com logoGLPG Awaits SAPHIRA Data, VTAE Vaults, CBLI Hits A Snag (NASDAQ:CBLI)
www.rttnews.com - March 17 at 2:04 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Other Events (NASDAQ:CBLI)
biz.yahoo.com - March 16 at 2:50 PM
finance.yahoo.com logoCleveland BioLabs Provides Update on Pre-EUA Review of Entolimod as Radiation Countermeasure (NASDAQ:CBLI)
finance.yahoo.com - March 16 at 2:00 PM
investorplace.com logoHottest Services Stocks Now – CAI NEWT INST MOBL (NASDAQ:CBLI)
investorplace.com - March 8 at 11:42 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 10-K, Annual Report (NASDAQ:CBLI)
biz.yahoo.com - February 23 at 5:04 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CBLI)
biz.yahoo.com - February 22 at 10:35 AM
finance.yahoo.com logoCleveland BioLabs Reports 2015 Financial Results and Development Progress (NASDAQ:CBLI)
finance.yahoo.com - February 22 at 7:30 AM
biz.yahoo.com logoCleveland BioLabs, Inc. (CBLI) (NASDAQ:CBLI)
biz.yahoo.com - February 18 at 6:31 PM
investorplace.com logoHottest Services Stocks Now – ADUS SREV EBIX CBLI (NASDAQ:CBLI)
investorplace.com - February 9 at 10:47 AM
streetinsider.com logoCleveland Biolabs (CBLI) Says Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis (NASDAQ:CBLI)
www.streetinsider.com - February 9 at 10:47 AM
finance.yahoo.com logoEntolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis in Studies by Cleveland BioLabs and Roswell Park Cancer Institute (NASDAQ:CBLI)
finance.yahoo.com - February 9 at 7:30 AM
finance.yahoo.com logoCleveland BioLabs Announces Start of Colorectal Cancer Study of Entolimod in Russian Federation (NASDAQ:CBLI)
finance.yahoo.com - February 2 at 8:00 AM
publicnow.com logoCleveland BioLabs Announces Start of Phase 2 Study of CBLB612 in Russian Federation (NASDAQ:CBLI)
www.publicnow.com - January 26 at 7:49 AM
finance.yahoo.com logoCleveland BioLabs Gets Orphan Status for Entolimod in EU (NASDAQ:CBLI)
finance.yahoo.com - January 22 at 3:25 PM
noodls.com logoCleveland BioLabs Attains Orphan Drug Status From the EMA for Entolimod as a Radiation Countermeasure (NASDAQ:CBLI)
www.noodls.com - January 21 at 7:45 AM
finance.yahoo.com logo7:30 am Cleveland Biolabs announces that entolimod has been granted orphan drug status by the EMA for treatment of acute radiation syndrome (NASDAQ:CBLI)
finance.yahoo.com - January 21 at 7:30 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Defin (NASDAQ:CBLI)
biz.yahoo.com - December 24 at 1:04 PM
noodls.com logoCleveland BioLabs and Rusnano Make Additional Investments in Panacela (NASDAQ:CBLI)
www.noodls.com - December 22 at 7:40 AM
capitalcube.com logoCleveland BioLabs, Inc. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:CBLI)
www.capitalcube.com - December 16 at 1:16 PM
finance.yahoo.com logoEntolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma in Collaborative Study by Cleveland BioLabs, Emory University and Roswell Park Cancer Institute (NASDAQ:CBLI)
finance.yahoo.com - December 14 at 7:30 AM
finance.yahoo.com logoCLEVELAND BIOLABS INC Financials (NASDAQ:CBLI)
finance.yahoo.com - December 8 at 1:17 PM
noodls.com logoCleveland BioLabs Announces Expanded U.S. Patent Protection for Entolimod (NASDAQ:CBLI)
www.noodls.com - November 30 at 8:00 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:CBLI)
biz.yahoo.com - November 9 at 4:17 PM
noodls.com logoCleveland BioLabs Reports Third Quarter 2015 Financial Results and Development Progress (NASDAQ:CBLI)
www.noodls.com - November 5 at 7:40 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:CBLI)
biz.yahoo.com - November 5 at 7:31 AM
biz.yahoo.com logoQ3 2015 Cleveland Biolabs Inc Earnings Release - Time Not Supplied (NASDAQ:CBLI)
biz.yahoo.com - November 5 at 7:07 AM
noodls.com logoCleveland BioLabs to Report Third Quarter 2015 Financial Results on November 5 (NASDAQ:CBLI)
www.noodls.com - October 27 at 8:15 AM

Social

Cleveland BioLabs (NASDAQ:CBLI) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff